Impaired ANT activity suppresses fatty acid oxidation (FAO) and promotes lipid accumulation in diabetic cardiomyopathy [97], while pharmacological inhibition of carnitine palmitoyltransferase 1 (CPT1) alleviates heart failure but risks lipotoxicity. The gene discussed is SLC25A4; the disease is heart failure.